Cargando…

Interstitial lung disease in systemic sclerosis: challenges in early diagnosis and management

Interstitial lung disease (ILD) is a group of lung diseases characterized by thickening of the interstitium surrounding pulmonary alveolar walls. It is related to specific radiographic features in lung imaging and/or the presence of restrictive disorders in pulmonary function tests (PFTs). ILD is on...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chowaniec, Małgorzata, Skoczyńska, Marta, Sokolik, Renata, Wiland, Piotr
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Narodowy Instytut Geriatrii, Reumatologii i Rehabilitacji w Warszawie 2018
Materias:	Review Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6142027/ https://www.ncbi.nlm.nih.gov/pubmed/30237630 http://dx.doi.org/10.5114/reum.2018.77977

Ejemplares similares

Relapsing polychondritis – analysis of symptoms and criteria
por: Maciążek-Chyra, Beata, et al.
Publicado: (2019)

Pathophysiology of hyperuricemia and its clinical significance – a narrative review
por: Skoczyńska, Marta, et al.
Publicado: (2020)

Erythema nodosum – review of the literature
por: Chowaniec, Małgorzata, et al.
Publicado: (2016)

Erythema nodosum – presentation of three cases
por: Starba, Aleksandra, et al.
Publicado: (2016)

Tofacitinib in the treatment of active rheumatoid arthritis – single-centre experience
por: Madej, Marta, et al.
Publicado: (2019)

The Challenge of Diagnosing and Managing Pulmonary Arterial Hypertension in Systemic Sclerosis with Interstitial Lung Disease
por: Zanatta, Elisabetta, et al.
Publicado: (2022)

Difficulties in diagnosis of systemic sclerosis-related interstitial lung disease
por: Vrancken, Anniek, et al.
Publicado: (2015)

Diagnosis and management of drug-associated interstitial lung disease
por: Müller, N L, et al.
Publicado: (2004)

Interstitial Lung Disease in Systemic Lupus Erythematosus and Systemic Sclerosis: How Can We Manage the Challenge?
por: Richter, Patricia, et al.
Publicado: (2023)

Challenges in the Diagnosis and Management of Patients with Fibrosing Interstitial Lung Disease
por: Tolle, Leslie B.
Publicado: (2022)

Interstitial Lung Disease in Systemic Sclerosis: Focus on Early Detection and Intervention
por: Fischer, Aryeh, et al.
Publicado: (2019)

Cytokine profiles in axial spondyloarthritis
por: Madej, Marta, et al.
Publicado: (2015)

Expert consensus on the management of systemic sclerosis-associated interstitial lung disease
por: Rahaghi, Franck F., et al.
Publicado: (2023)

Relationship Between Interleukin-6 −174G/C Genetic Variant and Efficacy of Methotrexate Treatment in Psoriatic Arthritis Patients
por: Sokolik, Renata, et al.
Publicado: (2021)

Epidemiology of systemic sclerosis and systemic sclerosis-associated interstitial lung disease
por: Bergamasco, Aurore, et al.
Publicado: (2019)

Interstitial lung disease pathology in systemic sclerosis
por: Konopka, Kristine E., et al.
Publicado: (2021)

Diagnosis and management of interstitial lung disease
por: Meyer, Keith C
Publicado: (2014)

Challenges in physician-patient communication for optimal management of systemic sclerosis-associated interstitial lung disease: a discourse analysis
por: Denton, Christopher P., et al.
Publicado: (2020)

Systemic Sclerosis Associated Interstitial Lung Disease: New Directions in Disease Management
por: Mirsaeidi, Mehdi, et al.
Publicado: (2019)

Journal Club: Efficacy of Tocilizumab in Early Systemic Sclerosis–Related Interstitial Lung Disease
por: Tiwari, Vivekanand, et al.
Publicado: (2021)

Risk Stratifying Interstitial Lung Abnormalities to Guide Early Diagnosis of Interstitial Lung Diseases
por: Wijsenbeek, Marlies S., et al.
Publicado: (2022)

Circulating Biomarkers of Interstitial Lung Disease in Systemic Sclerosis
por: Lota, Harpreet K., et al.
Publicado: (2012)

Recent Treatments of Interstitial Lung Disease with Systemic Sclerosis
por: Yasuoka, Hidekata
Publicado: (2016)

Pathogenesis of systemic sclerosis associated interstitial lung disease
por: Nihtyanova, Svetlana I, et al.
Publicado: (2020)

Incidence and prevalence of systemic sclerosis and systemic sclerosis with interstitial lung disease in the United States
por: Fan, Yanni, et al.
Publicado: (2020)

Progressive interstitial lung disease in patients with systemic sclerosis-associated interstitial lung disease in the EUSTAR database
por: Hoffmann-Vold, Anna-Maria, et al.
Publicado: (2021)

The potential and challenges of radiomics in uncovering prognostic and molecular differences in interstitial lung disease associated with systemic sclerosis
por: Zhang, Lu, et al.
Publicado: (2022)

Genetic Susceptibility to Interstitial Lung Disease Associated with Systemic Sclerosis
por: Tochimoto, Akiko, et al.
Publicado: (2016)

Rituximab treatment in patients with systemic sclerosis and interstitial lung disease
por: Mohammed, Abdel Gaffar A., et al.
Publicado: (2017)

Interstitial lung disease associated with systemic sclerosis (SSc-ILD)
por: Cottin, Vincent, et al.
Publicado: (2019)

Predictors of progression in systemic sclerosis patients with interstitial lung disease
por: Distler, Oliver, et al.
Publicado: (2020)

Detection and Monitoring of Interstitial Lung Disease in Patients with Systemic Sclerosis
por: Khanna, Surabhi Agarwal, et al.
Publicado: (2022)

Diagnosis and monitoring of systemic sclerosis-associated interstitial lung disease using high-resolution computed tomography
por: Khanna, Dinesh, et al.
Publicado: (2022)

Management of Patients with Systemic Sclerosis-Associated Interstitial Lung Disease: A Focus on the Role of the Pharmacist
por: Farrell, Jessica, et al.
Publicado: (2023)

State of the art in the diagnosis and management of interstitial lung disease
por: BUZAN, MARIA T. A., et al.
Publicado: (2015)

Diagnosis and Pharmacologic Management of Fibrotic Interstitial Lung Disease
por: Berger, Kristin, et al.
Publicado: (2023)

Predictors of interstitial lung disease in early systemic sclerosis: a prospective longitudinal study of the GENISOS cohort
por: Assassi, Shervin, et al.
Publicado: (2010)

Biomarkers in systemic sclerosis-associated interstitial lung disease: review of the literature
por: Bonhomme, Olivier, et al.
Publicado: (2019)

Patient and Physician Perspectives on Systemic Sclerosis–Associated Interstitial Lung Disease
por: Cheema, Tariq J, et al.
Publicado: (2020)

Etiology, Risk Factors, and Biomarkers in Systemic Sclerosis with Interstitial Lung Disease
por: Khanna, Dinesh, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_slu50i6ihsonbim4pbps5s8ql5